8-K filed Nov 5, 2026 at 09:04 ET
Myriad Genetics disclosed a cybersecurity incident on November 2, 2026, involving unauthorized access to its IT network. The company temporarily suspended testing operations and order management systems, and most systems have since returned to normal. Management does not believe the incident will have a material adverse effect on its business, but the investigation into the scope, including potential patient record access, is ongoing.